The “Undetermined Significance” of (18)F-FDG PET/CT or PET/MRI in Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS)

Monoclonal gammopathy of undetermined significance (MGUS) is a highly prevalent condition with the possible risk of progression to multiple myeloma (MM) or a lymphoproliferative neoplasm in a small percentage of patients. Fluorine-18 fluorodeoxyglucose ((18)F-FDG) positron emission tomography/comput...

Descripción completa

Detalles Bibliográficos
Autores principales: Treglia, Giorgio, Bertagna, Francesco, Albano, Domenico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8401289/
https://www.ncbi.nlm.nih.gov/pubmed/34441062
http://dx.doi.org/10.3390/medicina57080856
_version_ 1783745515386568704
author Treglia, Giorgio
Bertagna, Francesco
Albano, Domenico
author_facet Treglia, Giorgio
Bertagna, Francesco
Albano, Domenico
author_sort Treglia, Giorgio
collection PubMed
description Monoclonal gammopathy of undetermined significance (MGUS) is a highly prevalent condition with the possible risk of progression to multiple myeloma (MM) or a lymphoproliferative neoplasm in a small percentage of patients. Fluorine-18 fluorodeoxyglucose ((18)F-FDG) positron emission tomography/computed tomography (PET/CT) or positron emission tomography/magnetic resonance imaging (PET/MRI) are imaging methods increasingly used in patients with MM. The aim of this communication is to underline that, taking into account current evidence-based data, compared to MM the role of (18)F-FDG PET/CT or PET/MRI in MGUS is still undetermined and more studies should be performed before suggesting (18)F-FDG PET/CT or PET/MRI for evaluation of MM progression in patients with MGUS.
format Online
Article
Text
id pubmed-8401289
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-84012892021-08-29 The “Undetermined Significance” of (18)F-FDG PET/CT or PET/MRI in Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS) Treglia, Giorgio Bertagna, Francesco Albano, Domenico Medicina (Kaunas) Communication Monoclonal gammopathy of undetermined significance (MGUS) is a highly prevalent condition with the possible risk of progression to multiple myeloma (MM) or a lymphoproliferative neoplasm in a small percentage of patients. Fluorine-18 fluorodeoxyglucose ((18)F-FDG) positron emission tomography/computed tomography (PET/CT) or positron emission tomography/magnetic resonance imaging (PET/MRI) are imaging methods increasingly used in patients with MM. The aim of this communication is to underline that, taking into account current evidence-based data, compared to MM the role of (18)F-FDG PET/CT or PET/MRI in MGUS is still undetermined and more studies should be performed before suggesting (18)F-FDG PET/CT or PET/MRI for evaluation of MM progression in patients with MGUS. MDPI 2021-08-23 /pmc/articles/PMC8401289/ /pubmed/34441062 http://dx.doi.org/10.3390/medicina57080856 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Communication
Treglia, Giorgio
Bertagna, Francesco
Albano, Domenico
The “Undetermined Significance” of (18)F-FDG PET/CT or PET/MRI in Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS)
title The “Undetermined Significance” of (18)F-FDG PET/CT or PET/MRI in Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS)
title_full The “Undetermined Significance” of (18)F-FDG PET/CT or PET/MRI in Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS)
title_fullStr The “Undetermined Significance” of (18)F-FDG PET/CT or PET/MRI in Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS)
title_full_unstemmed The “Undetermined Significance” of (18)F-FDG PET/CT or PET/MRI in Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS)
title_short The “Undetermined Significance” of (18)F-FDG PET/CT or PET/MRI in Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS)
title_sort “undetermined significance” of (18)f-fdg pet/ct or pet/mri in patients with monoclonal gammopathy of undetermined significance (mgus)
topic Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8401289/
https://www.ncbi.nlm.nih.gov/pubmed/34441062
http://dx.doi.org/10.3390/medicina57080856
work_keys_str_mv AT tregliagiorgio theundeterminedsignificanceof18ffdgpetctorpetmriinpatientswithmonoclonalgammopathyofundeterminedsignificancemgus
AT bertagnafrancesco theundeterminedsignificanceof18ffdgpetctorpetmriinpatientswithmonoclonalgammopathyofundeterminedsignificancemgus
AT albanodomenico theundeterminedsignificanceof18ffdgpetctorpetmriinpatientswithmonoclonalgammopathyofundeterminedsignificancemgus
AT tregliagiorgio undeterminedsignificanceof18ffdgpetctorpetmriinpatientswithmonoclonalgammopathyofundeterminedsignificancemgus
AT bertagnafrancesco undeterminedsignificanceof18ffdgpetctorpetmriinpatientswithmonoclonalgammopathyofundeterminedsignificancemgus
AT albanodomenico undeterminedsignificanceof18ffdgpetctorpetmriinpatientswithmonoclonalgammopathyofundeterminedsignificancemgus

Ejemplares similares